248 related articles for article (PubMed ID: 33904583)
1. Clinical and Host Biological Factors Predict Colectomy Risk in Children Newly Diagnosed With Ulcerative Colitis.
Hyams JS; Brimacombe M; Haberman Y; Walters T; Gibson G; Mo A; Mack D; Griffiths A; Boyle B; LeLeiko N; Markowitz J; Rosh J; Patel A; Shah S; Baldassano R; Pfefferkorn M; Sauer C; Dailey J; Venkateswaran S; Kugathasan S; Denson LA
Inflamm Bowel Dis; 2022 Feb; 28(2):151-160. PubMed ID: 33904583
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with early outcomes following standardised therapy in children with ulcerative colitis (PROTECT): a multicentre inception cohort study.
Hyams JS; Davis S; Mack DR; Boyle B; Griffiths AM; LeLeiko NS; Sauer CG; Keljo DJ; Markowitz J; Baker SS; Rosh J; Baldassano RN; Patel A; Pfefferkorn M; Otley A; Heyman M; Noe J; Oliva-Hemker M; Rufo P; Strople J; Ziring D; Guthery SL; Sudel B; Benkov K; Wali P; Moulton D; Evans J; Kappelman MD; Marquis A; Sylvester FA; Collins MH; Venkateswaran S; Dubinsky M; Tangpricha V; Spada KL; Britt A; Saul B; Gotman N; Wang J; Serrano J; Kugathasan S; Walters T; Denson LA
Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):855-868. PubMed ID: 28939374
[TBL] [Abstract][Full Text] [Related]
3. Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study.
Hyams JS; Davis Thomas S; Gotman N; Haberman Y; Karns R; Schirmer M; Mo A; Mack DR; Boyle B; Griffiths AM; LeLeiko NS; Sauer CG; Keljo DJ; Markowitz J; Baker SS; Rosh J; Baldassano RN; Patel A; Pfefferkorn M; Otley A; Heyman M; Noe J; Oliva-Hemker M; Rufo PA; Strople J; Ziring D; Guthery SL; Sudel B; Benkov K; Wali P; Moulton D; Evans J; Kappelman MD; Marquis MA; Sylvester FA; Collins MH; Venkateswaran S; Dubinsky M; Tangpricha V; Spada KL; Saul B; Wang J; Serrano J; Hommel K; Marigorta UM; Gibson G; Xavier RJ; Kugathasan S; Walters T; Denson LA
Lancet; 2019 Apr; 393(10182):1708-1720. PubMed ID: 30935734
[TBL] [Abstract][Full Text] [Related]
4. Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative Colitis.
Taxonera C; Barreiro-de Acosta M; Calvo M; Saro C; Bastida G; Martín-Arranz MD; Gisbert JP; García-Sánchez V; Marín-Jiménez I; Bermejo F; Chaparro M; Ponferrada Á; Martínez-Montiel MP; Pajares R; de Gracia C; Olivares D; Alba C; Mendoza JL; Fernández-Blanco I
Dig Dis Sci; 2015 Oct; 60(10):3075-84. PubMed ID: 26044830
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab.
Turner D; Griffiths AM; Veerman G; Johanns J; Damaraju L; Blank M; Hyams J
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1460-5. PubMed ID: 23672831
[TBL] [Abstract][Full Text] [Related]
6. Incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics.
Williet N; Pillot C; Oussalah A; Billioud V; Chevaux JB; Bresler L; Bigard MA; Gueant JL; Peyrin-Biroulet L
Inflamm Bowel Dis; 2012 Sep; 18(9):1641-6. PubMed ID: 22139830
[TBL] [Abstract][Full Text] [Related]
7. Impact of Changing Treatment Strategies on Outcomes in Pediatric Ulcerative Colitis.
Bolia R; Rajanayagam J; Hardikar W; Alex G
Inflamm Bowel Dis; 2019 Oct; 25(11):1838-1844. PubMed ID: 31002341
[TBL] [Abstract][Full Text] [Related]
8. Post-induction infliximab trough levels and disease activity in the clinical evolution of pediatric ulcerative colitis.
Moore H; Dolce P; Devas N; Baldassano R; Martinelli M
United European Gastroenterol J; 2020 May; 8(4):425-435. PubMed ID: 32213038
[TBL] [Abstract][Full Text] [Related]
9. Early endoscopic, laboratory and clinical predictors of poor disease course in paediatric ulcerative colitis.
Schechter A; Griffiths C; Gana JC; Shaoul R; Shamir R; Shteyer E; Bdolah-Abram T; Ledder O; Turner D
Gut; 2015 Apr; 64(4):580-8. PubMed ID: 24848266
[TBL] [Abstract][Full Text] [Related]
10. Risk matrix model for prediction of colectomy in a population-based study of ulcerative colitis patients (the IBSEN study).
Solberg IC; Høivik ML; Cvancarova M; Moum B;
Scand J Gastroenterol; 2015; 50(12):1456-62. PubMed ID: 26139389
[TBL] [Abstract][Full Text] [Related]
11. Targeted Assessment of Mucosal Immune Gene Expression Predicts Clinical Outcomes in Children with Ulcerative Colitis.
Clarkston K; Karns R; Jegga AG; Sharma M; Fox S; Ojo BA; Minar P; Walters TD; Griffiths AM; Mack DR; Boyle B; LeLeiko NS; Markowitz J; Rosh JR; Patel AS; Shah S; Baldassano RN; Pfefferkorn M; Sauer C; Kugathasan S; Haberman Y; Hyams JS; Denson LA; Rosen MJ
J Crohns Colitis; 2022 Nov; 16(11):1735-1750. PubMed ID: 35665804
[TBL] [Abstract][Full Text] [Related]
12. Early Change in Fecal Calprotectin Predicts One-Year Outcome in Children Newly Diagnosed With Ulcerative Colitis.
Krishnakumar C; Ananthakrishnan AN; Boyle BM; Griffiths AM; LeLeiko NS; Mack DR; Markowitz JF; Rosh JR; Sauer CG; Walters TD; Bonkowski E; Denson LA; Hyams JS; Kugathasan S
J Pediatr Gastroenterol Nutr; 2022 Jan; 74(1):72-78. PubMed ID: 34433783
[TBL] [Abstract][Full Text] [Related]
13. Managing paediatric acute severe ulcerative colitis according to the 2011 ECCO-ESPGHAN guidelines: Efficacy of infliximab as a rescue therapy.
Aloi M; D'Arcangelo G; Capponi M; Nuti F; Vassallo F; Civitelli F; Oliva S; Pagliaro G; Cucchiara S
Dig Liver Dis; 2015 Jun; 47(6):455-9. PubMed ID: 25733340
[TBL] [Abstract][Full Text] [Related]
14. Induction and maintenance infliximab therapy in children with moderate to severe ulcerative colitis: Retrospective, multicenter study.
Iwańczak BM; Kierkuś J; Ryżko J; Szczepanik M; Więcek S; Czaja-Bulsa G; Kacperska M; Korczowski B; Maślana J; Iwańczak F
Adv Clin Exp Med; 2017; 26(1):57-61. PubMed ID: 28397433
[TBL] [Abstract][Full Text] [Related]
15. Long-term Outcomes of Paediatric Patients Admitted With Acute Severe Colitis- A Multicentre Study From the Paediatric IBD Porto Group of ESPGHAN.
Krauthammer A; Tzivinikos C; Assa A; Miele E; Strisciuglio C; Urlep D; Serban ED; Singh A; Winter HS; Russell RK; Hojsak I; Malham M; Navas-López VM; Croft NM; Lee HM; Ledder O; Shamasneh I; Hussey S; Huynh HQ; Wine E; Shah N; Sladek M; de Meij TG; Romano C; Dipasquale V; Lionetti P; Afzal NA; Aloi M; Lee K; Martín-de-Carpi J; Yerushalmy-Feler A; Subramanian S; Weiss B; Shouval DS
J Crohns Colitis; 2019 Dec; 13(12):1518-1526. PubMed ID: 31120524
[TBL] [Abstract][Full Text] [Related]
16. Evolution and predictive factors of relapse in ulcerative colitis patients treated with mesalazine after a first course of corticosteroids.
Bello C; Belaiche J; Louis E; Reenaers C
J Crohns Colitis; 2011 Jun; 5(3):196-202. PubMed ID: 21575881
[TBL] [Abstract][Full Text] [Related]
17. Colectomy is a risk factor for venous thromboembolism in ulcerative colitis.
Kaplan GG; Lim A; Seow CH; Moran GW; Ghosh S; Leung Y; Debruyn J; Nguyen GC; Hubbard J; Panaccione R
World J Gastroenterol; 2015 Jan; 21(4):1251-60. PubMed ID: 25632199
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of patients with acute ulcerative colitis after first course of intravenous corticosteroids.
Eronen H; Ilus T; Jussila A; Huhtala H; Collin P; Oksanen P
Scand J Gastroenterol; 2021 Mar; 56(3):234-238. PubMed ID: 33496198
[TBL] [Abstract][Full Text] [Related]
19. Intensified Infliximab Induction is Associated with Improved Response and Decreased Colectomy in Steroid-Refractory Paediatric Ulcerative Colitis.
Church PC; Ho S; Sharma A; Tomalty D; Frost K; Muise A; Walters TD; Griffiths AM
J Crohns Colitis; 2019 Aug; 13(8):982-989. PubMed ID: 30715240
[TBL] [Abstract][Full Text] [Related]
20. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
